Chemokine (C-C Motif) Ligand 17 (CCL17) ELISA Kits

CCL17 is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Additionally we are shipping CCL17 Antibodies (178) and CCL17 Proteins (51) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
CCL17 6361 Q92583
CCL17 20295  
CCL17 117518  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top CCL17 ELISA Kits at

Showing 10 out of 30 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Human 1pg/mL 31.2-2000 pg/mL Human CCL17/TARC PicoKine ELISA Kit standard curve 96 Tests 4 to 6 Days
Mouse 10pg/mL 31.2-2000 pg/mL Mouse CCL17/TARC PicoKine ELISA Kit standard curve 96 Tests 4 to 6 Days
Rat 5.5 pg/mL 15.6 pg/mL - 1000 pg/mL 96 Tests 13 to 16 Days
Monkey 9.8 pg/mL 39-2500 pg/mL Typical standard curve 96 Tests 15 to 18 Days
Dog 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 to 18 Days
Guinea Pig 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 to 18 Days
Rabbit 1.0 pg/mL 250-5000 pg/mL   96 Tests 15 to 18 Days
Human 0.5 pg/mL n/a   96 Tests 11 to 16 Days
Mouse 0.4 pg/mL n/a   96 Tests 11 to 16 Days
  96 Tests 15 to 18 Days

Top referenced CCL17 ELISA Kits

  1. Human CCL17 ELISA Kit for Sandwich ELISA - ABIN625091 : García, Cidoncha, Bote, Hinchado, Ortega: Altered profile of chemokines in fibromyalgia patients. in Annals of clinical biochemistry 2014 (PubMed)
    Show all 5 Pubmed References

  2. Human CCL17 ELISA Kit for Sandwich ELISA - ABIN921088 : Zhang, He: Overexpression of mclca3 in airway epithelium of asthmatic murine models with airway inflammation. in Chinese medical journal 2010 (PubMed)
    Show all 4 Pubmed References

More ELISA Kits for CCL17 Interaction Partners

Human Chemokine (C-C Motif) Ligand 17 (CCL17) interaction partners

  1. Case series study and literature review suggest that TARC play some roles in the production of systemic sclerosis (SSc)-specific autoantibodies and development of concomitance with SSc in sarcoidosis, although the mechanisms remain unknown. [Review]

  2. Study suggests that a high serum TARC level is a diagnostic feature of papuloerythroderma of Ofuji (PEO) and that the serum TARC level may be useful for monitoring disease activity in PEO, although the precise pathogenesis of the condition remains unclear.

  3. IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line.

  4. TARC may contribute to the development of SLE through an aberrant induction of CD4(+)CD52(lo) T cells.

  5. The CCL17 SNP rs223828 is associated with increased risk of CAD, and this site may be a potential AP-1 binding site.

  6. IL4 induces CCL17 production by acting through IRF4 in human monocytes and murine macrophages.

  7. The frequency of the CC genotype in the TARC rs223828 SNP was higher in patients with intractable Graves disease than in patients with Graves disease in remission.

  8. The expression of CCL17 was decreased in nasal polyp (NP) epithelium compared to the epithelium of normal ethmoid sinus, whereas the expression of CCL22 was not decreased. E-cadherin was differentially distributed between the epithelium of normal ethmoid sinus and NP epithelium. EGFR was also decreased in NPs.

  9. TARC serum levels were elevated in 78% of sarcoidosis patients and correlated with disease severity.

  10. Serum TARC level may be a potent marker reflecting better response to IL-17A inhibitors for psoriasis treatment.

  11. This review presents key clinical studies of Multiple sclerosis together with experimental studies in animals that have demonstrated functional roles of CCR4, CCL17, and CCL22 in experimental autoimmune encephalomyelitis pathogenesis. [review]

  12. Taken together, our data showed a likely positive feedback mechanism of enhanced IL-6 production in ectopic milieu. The high levels of IL-6 in the peritoneal cavity stimulate the expression of CCL17 in endometrial stromal cells by activating JNK signal pathway, and then, CCL17 further induces CCR4 expression on macrophages, which eventually leads to an increase in IL-6 production via NF-kappaB activation.

  13. Data suggest that high levels of CCL17 and CCL22 in endometrium in women with endometriosis promote (1) recruitment of Tregs, (2) immunosuppression of Tregs, and (3) angiogenesis in endometrium. (Tregs = regulatory T cells)

  14. Serum TARC levels correlate well with indicators of systemic inflammation and of disease severity among patients with a drug eruption except SJS/TEN. Serum TARC may be a prognostic biomarker of severity of inflammation in drug eruptions.

  15. TARC production in HaCaT keratinocytes through the interaction between IL-22 and IL-22Ralpha facilitates T-cell migration in atopic dermatitis caused by house dust mites.

  16. TARC is a candidate biomarker for PTSD only in males.

  17. High CCL17 expression is associated with colon cancer cell migration.

  18. GM-CSF can mediate inflammation and pain by regulating IRF4-induced CCL17 production

  19. Based on the ADEPT study data set, we report that airway mucosal expression of CCL26 was a robust discriminator of type 2 inflammation from healthy nonatopic subjects. Furthermore, airway mucosal CCL26 expression was best identified by using a panel of clinical biomarkers, including Feno values, bEOS counts, and expression of 2 novel markers, sCCL17 and sCCL26

  20. Low CCL17 expression is a potential independent adverse prognostic biomarker for recurrence and survival of patients with clear cell renal cell carcinoma after nephrectomy.

Mouse (Murine) Chemokine (C-C Motif) Ligand 17 (CCL17) interaction partners

  1. Basal expression of Ccl17 in hippocampal neurons was strongly enhanced by peripheral challenge with lipopolysaccharide (LPS). LPS-mediated induction of Ccl17 in the hippocampus was dependent on local tumor necrosis factor signaling, whereas upregulation of Ccl22 required granulocyte-macrophage colony-stimulating factorCCL17 deficiency resulted in a diminished microglia density under homeostatic and inflammatory conditions

  2. IL4 induces CCL17 production by acting through IRF4 in human monocytes and murine macrophages.

  3. Study identifies CC chemokine ligand 17 as a unique modulator of experimental autoimmune encephalomyelitis (EAE) pathogenesis regulating dendritic cell trafficking as well as peripheral Treg cell expansion in EAE.

  4. GM-CSF can mediate inflammation and pain by regulating IRF4-induced CCL17 production

  5. the M2 macrophage chemokine CCL17 was identified as an essential factor for enhanced survival in the absence of CB2, because CCL17 x Cnr2 double-deficient mice were fully susceptible to experimental cerebral malaria.

  6. Aged mice had similar levels of IL-1beta, TNF, IFN-gamma, IL-17, and granulocyte colony-stimulating factor following S. pneumoniae infection, compared with young mice, but increased levels of the chemokines CXCL9, CXCL12, CCL3, CCL4, CCL5, CCL11, and CCL17.

  7. that effective engagement of CCR4 by CCL17 involves two distinct binding domains and interaction with both is required for signaling

  8. murine tumor-associated neutrophils secrete significant amounts of CCL17. Migration assays showed recruitment of T-regs by tumor-associated neutrophils, which was inhibited with anti-CCL17 monoclonal antibodies.

  9. TSLP activated a subset of CD11b(+) DCs in the skin to produce CCL17, upregulate CCR7, and migrate to the draining lymph node to initiate Th2 differentiation.

  10. CCL17 is required for induction of intestinal inflammation in mice and has an autocrine effect on dendritic cells that promotes production of inflammatory cytokines and activation of Th1 and Th17 cells and reduces expansion of Treg cells.

  11. Kinetics of CCL17 mRNA expression in an allergic contact dermatitis model.

  12. Thymus and activation-regulated chemokine (TARC)/CC chemokine ligand (CCL) 17 accelerates wound healing by enhancing fibroblast migration.

  13. Data identify DC-derived CCL17 as a central regulator of Treg homeostasis, implicate DCs and their effector functions in atherogenesis, and suggest that CCL17 might be a target for vascular therapy.

  14. Data show that mice deficient for CCL17 had an up to 4-fold higher worm burden compared with controls by day 10 of infection with the murine filaria Litomosoides sigmodontis.

  15. The inducible chemokine CCL17 sensitizes dendritic cells (DCs) for CCR7- and CXCR4-dependent migration to lymph node-associated homeostatic chemokines under inflammatory conditions and thus plays an important role in cutaneous DC migration.

  16. we report an unexpected role for CCR4 and CCL17 in NKT cell-licensed cross-priming.

  17. These findings indicate that CCL17 production is a hallmark of local dendritic cell stimulation in peripheral organs but is absent from the spleen as a filter of blood-borne antigens

  18. CCL17 released from peritoneal macrophages generated in mice with third-degree burn injuries inhibits generation of resident macrophages from normal mice stimulated in vitro with CpG DNA.

  19. CCL17 has an important role in the development of pulmonary fibrosis via the recruitment of lymphocytes and macrophages. Neutralization of CCL17, but not CCL22, leads to a reduction in pulmonary fibrosis.

  20. CCL17-CCR4 interactions dramatically impair the pulmonary antifungal response against A. fumigatus in neutropenic mice.

CCL17 Antigen Profile

Antigen Summary

This gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for T lymphocytes, but not monocytes or granulocytes. The product of this gene binds to chemokine receptors CCR4 and CCR8. This chemokine plays important roles in T cell development in thymus as well as in trafficking and activation of mature T cells.

Gene names and symbols associated with CCL17

  • C-C motif chemokine ligand 17 (CCL17) antibody
  • chemokine (C-C motif) ligand 17 (Ccl17) antibody
  • C-C motif chemokine ligand 17 (Ccl17) antibody
  • ATP-binding cassette sub-family D member 2 (LOC100537809) antibody
  • A-152E5.3 antibody
  • Abcd-2 antibody
  • abcd2 antibody
  • CCL17 antibody
  • Scya17 antibody
  • Scya17l antibody
  • Tarc antibody

Protein level used designations for CCL17

C-C motif chemokine 17 , CC chemokine TARC , T cell-directed CC chemokine , small inducible cytokine subfamily A (Cys-Cys), member 17 , small-inducible cytokine A17 , thymus and activation-regulated chemokine , chemokine (C-C motif) ligand 17 , chemokine CCL17/TARC , small inducible cytokine A17 , small inducible cytokine subfamily A17 , chemokine ligand 17-like protein , ATP-binding cassette sub-family D member 2 , ATP-binding cassette, sub-family D (ALD), member 2

6361 Homo sapiens
415652 Gallus gallus
467985 Pan troglodytes
574180 Macaca mulatta
100140488 Bos taurus
403586 Canis lupus familiaris
20295 Mus musculus
117518 Rattus norvegicus
780408 Sus scrofa
493832 Felis catus
100715805 Cavia porcellus
101120186 Ovis aries
100537809 Danio rerio
Selected quality suppliers for CCL17 (CCL17) ELISA Kits
Did you look for something else?